JG
AMRI

Jefferies Group’s Albany Molecular Research Inc AMRI Stock Holding History

Jefferies Group’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-19,065
Closed -$414K – 2781
2017
Q2 		$414K Buy
+19,065
New +$346K ﹤0.01% 1696

Other funds holding AMRI

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Jefferies Group's AMRI Position: Q3 2017 in Review

Jefferies Group sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 19,065 shares — an estimated $414K sold.

Jefferies Group first reported a position in AMRI in Q2 2017 and held it in 1 quarter. The position peaked at $414K in Q2 2017. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

  • Jefferies Group reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
  • Jefferies Group sold 19,065 Albany Molecular Research Inc shares in Q3 2017, an estimated $414K.
  • Jefferies Group first reported a position in Albany Molecular Research Inc in Q2 2017 and held it in 1 quarter.
  • Jefferies Group's Albany Molecular Research Inc position peaked at $414K in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on Jefferies Group's 13F filing for Q3 2017, filed 14 Nov 2017.